Home Cart 0 Sign in  

[ CAS No. 25699-83-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 25699-83-6
Chemical Structure| 25699-83-6
Structure of 25699-83-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 25699-83-6 ]

Related Doc. of [ 25699-83-6 ]

Alternatived Products of [ 25699-83-6 ]

Product Details of [ 25699-83-6 ]

CAS No. :25699-83-6 MDL No. :MFCD09033533
Formula : C10H7N3 Boiling Point : -
Linear Structure Formula :- InChI Key :SLPWCEHHSRUSKN-UHFFFAOYSA-N
M.W : 169.18 Pubchem ID :12079629
Synonyms :

Calculated chemistry of [ 25699-83-6 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 11
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 48.28
TPSA : 41.61 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.81 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.85
Log Po/w (XLOGP3) : 2.14
Log Po/w (WLOGP) : 1.74
Log Po/w (MLOGP) : 1.07
Log Po/w (SILICOS-IT) : 1.49
Consensus Log Po/w : 1.66

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.8
Solubility : 0.27 mg/ml ; 0.00159 mol/l
Class : Soluble
Log S (Ali) : -2.65
Solubility : 0.383 mg/ml ; 0.00226 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.01
Solubility : 0.167 mg/ml ; 0.000986 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.43

Safety of [ 25699-83-6 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H312-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 25699-83-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 25699-83-6 ]
  • Downstream synthetic route of [ 25699-83-6 ]

[ 25699-83-6 ] Synthesis Path-Upstream   1~14

  • 1
  • [ 25699-83-6 ]
  • [ 16209-00-0 ]
YieldReaction ConditionsOperation in experiment
45% With water; sodium hydroxide In ethanol at 105℃; for 16 h; A 250-mE round-bottom flask was charged with4-(1H-pyrazol-i-yl)benzonitrile (Step 1, 2 g, 11.82 mmol), ethanol (40 mE), water (40 mE) and sodium hydroxide (705 mg, 17.63 mmol). The resulting solution was stirred at 105° C. 16 hand then concentrated under vacuum. The residue was diluted with water (30 mE) and extracted with ethyl acetate (50 mE).12109] ThepHoftheaqueousphasewas adjustedto 5 with hydrochloric acid (6.0 M). The solids were collected by filtration, washed with water (10 mE) and dried in an oven to afford 4-(1H-pyrazol-i-yl)benzoic acid as a light yellow solid (Intermediate 2-60, 1 g, 45percent). LCMS: (ESI)m/z 189 [M+H].
45% With water; sodium hydroxide In ethanol at 105℃; for 16 h; A 250-mL round-bottom flask was charged with 4-(1H-pyrazol-1-yl)benzonitrile (Step 1, 2 g, 11.82 mmol), ethanol (40 mL), water (40 mL) and sodium hydroxide (705 mg, 17.63 mmol,). The resulting solution was stirred at 105° C. 16 h and then concentrated under vacuum. The residue was diluted with water (30 mL) and extracted with ethyl acetate (50 mL). The pH of the aqueous phase was adjusted to 5 with hydrochloric acid (6.0 M). The solids were collected by filtration, washed with water (10 mL) and dried in an oven to afford 4-(1H-pyrazol-1-yl)benzoic acid as a light yellow solid (Intermediate 2-13, 1 g, 45percent). LCMS: (ESI) m/z 189 [M+H].
Reference: [1] Patent: US2016/185785, 2016, A1, . Location in patent: Paragraph 2106; 2108
[2] Patent: US2016/185786, 2016, A1, . Location in patent: Paragraph 0630
  • 2
  • [ 288-13-1 ]
  • [ 1194-02-1 ]
  • [ 25699-83-6 ]
YieldReaction ConditionsOperation in experiment
87% With potassium carbonate In N,N-dimethyl-formamide at 120℃; for 7 h; 4-( 1 H-pyrazol- 1 -yl)- benzonitrile4-Fluorobenzonitrile (204.2 g), pyrazole (138.6 g, 1.22 eq) and potassium carbonate (281.5 g, 1.22 eq) in DMF (1110 ml) were heated at 120 0C for 7 hours. The suspension was cooled to 25 0C and water (2920 ml) added. The reaction was extracted with MTBE (3 x 1460 ml) and the combined extracts were washed with water (3 x 1460 ml) and saturated aqueous sodium chloride (1460 ml). The organic phase was concentrated at atmospheric pressure until the pot temperature rose to 65 0C. Heptane (1700 ml) was added over 30 minutes at 60-65 0C, and then a further 300 ml of distillate was collected. The solution was stirred at 60-65 0C for 15 minutes and then cooled to <5 0C. The slurry was filtered and washed with heptane (2 x 200 ml), and dried under vacuum to constant weight to give the title compound as a solid (245.3 g, 87percent). <n="47"/>1H NMR (400 MHz, CDCl3): 6.51 (q, IH), 7.71 (d, 2H), 7.75 (d, IH), 7.81 (d, 2H), 7.98 (d, IH).
83% With potassium carbonate In N,N-dimethyl-formamide at 115 - 120℃; for 7 - 8 h; Inert atmosphere 5f: 4-(1H-pyrazol-1-yl)benzonitrile N,N-dimethylformamide (123.25 L) was charged to the vessel and analysed for moisture content (target<0.5percent). Potassium carbonate (34.01 kg) was then charged to the vessel followed by pyrazole (16.76 kg) and 4-fluorobenzonitrile (24.65 kg). The reaction mixture was heated to 115 to 120° C. and stirred at this temperature for between seven and eight hours under a nitrogen atmosphere. The reaction was monitored by GC (target<10percent 4-fluorobenzonitrile). The reaction was then cooled to 20-25° C. and quenched with water (369.7 L). Methyl tert-butyl ether (246.5 L) was then charged and the layers allowed to separate. The aqueous layer was washed with methyl tert-butyl ether (2 x147.9 L) and the organic layers combined. The organic layer was then washed with water (2 x 172.55 L) and aqueous brine (123.25 L, 24 wt percent). The organic phase was then concentrated to approximately 100 L at 60° C. or below at atmospheric pressure. n-Heptane (209 L) was then charged and the mixture concentrated to approximately 100 L at 60° C. or below at atmospheric pressure. The reaction was cooled to 0° C. and stirred for three hours at this temperature. The slurry was then filtered washing the filter cake with n-heptane (24.65 L). The resulting solid was dried under vacuum at 40° C. to yield the title product (28.6 kg, 99.32percent purity, 83percent yield). 1H NMR (300 MHz, DMSO-d6): 6.61 (dd, J=2.4, 1.9 Hz, 1H), 7.83 (d, J=1.4 Hz 1H), 7.94 (d, J=8.7 Hz, 2H), 8.04 (d, J=9.0 Hz, 2H), 8.65 (d, J=2.4 Hz, 1H).
80% With potassium carbonate In N,N-dimethyl-formamide at 110℃; for 16 h; Step 1. 4-(lH-Pyrazol-l-yl)benzonitrile (0847) [00269] A mixture of lH-pyrazole (15 g, 220.34 mmol), 4-fluorobenzonitrile (27 g, 222.93 mmol), potassium carbonate (60.7 g, 439.19 mmol) in DMF (200 mL) was stirred for 16 h at 110 °C. After cooling to ambient temperature, the reaction mixture was poured into water (500 mL) and the resulting solids were collected by filtration and dried under vacuum, resulting in 30 g (80percent) of 4-(lH-pyrazol-l-yl)benzonitrile. MS (ESI) m/z 170 [M+H]+.
62%
Stage #1: With sodium hydroxide In N,N-dimethyl-formamide at 80℃; for 0.5 h; Inert atmosphere
Stage #2: at 110℃; for 3 h;
Into a 50-mL 3-necked round-bottom flask purged and maintained with an inert atmosphere of nitrogen, was placed 1H-pyrazole (422 mg, 6.21 mmol, 1.50 equiv), sodium hydroxide (248 mg, 6.20 mmol, 1.50 equiv), and N,N-dimethylformamide (20 mL).
The mixture was stirred and heated to 80° C. for 30 min, then to this was added 4-fluorobenzonitrile (500 mg, 4.13 mmol, 1.00 equiv).
The resulting solution was stirred for 3 h at 110° C. in an oil bath.
The resulting solution was diluted with 50 mL of H2O.
The solids were collected by filtration and dried in an oven.
The product was obtained as 0.43 g (62percent) of a white solid.
47% With caesium carbonate In N,N-dimethyl-formamide for 2 h; Reflux A 100-mE round-bottom flask was charged with4-fluorobenzonitrile (2 g, 16.51 mmol), cesium carbonate (16 g, 49.11 mmol), N,N-dimethylformamide (20 mE) and 1 H-pyrazole (2.24 g, 32.90 mmol). The resulting solution was refluxed for 2 h. The solids were removed by filtration and the filtrate was concentrated under vacuum. The residue was purified by column chromatography eluting with ethyl acetate/petroleum ether (1:10 to 1:4 v/v) to afford 4-(1H- pyrazol-i-yl)benzonitrile as a yellow oil (1.3 g, 47percent). LCMS: (ESI) mlz 170 [M+H].
47% With caesium carbonate In N,N-dimethyl-formamide for 2 h; Reflux A 100-mL round-bottom flask was charged with 4-fluorobenzonitrile (2 g, 16.51 mmol), cesium carbonate (16 g, 49.11 mmol), N,N-dimethylformamide (20 mL) and 1H-pyrazole (2.24 g, 32.90 mmol). The resulting solution was refluxed for 2 h. The solids were removed by filtration and the filtrate was concentrated under vacuum. The residue was purified by column chromatography eluting with ethyl acetate/petroleum ether (1:10 to 1:4 v/v) to afford 4-(1H-pyrazol-1-yl)benzonitrile as a yellow oil (1.3 g, 47percent). LCMS: (ESI) m/z 170 [M+H].

Reference: [1] Patent: WO2009/61271, 2009, A1, . Location in patent: Page/Page column 45-46
[2] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 11, p. 2955 - 2959
[3] Patent: US2011/224229, 2011, A1, . Location in patent: Page/Page column 19
[4] Patent: WO2017/87837, 2017, A1, . Location in patent: Paragraph 00269
[5] Patent: US9301951, 2016, B2, . Location in patent: Page/Page column 231
[6] Patent: US2016/185785, 2016, A1, . Location in patent: Paragraph 2106; 2107
[7] Patent: US2016/185786, 2016, A1, . Location in patent: Paragraph 0629
  • 3
  • [ 288-13-1 ]
  • [ 623-03-0 ]
  • [ 25699-83-6 ]
YieldReaction ConditionsOperation in experiment
51% With copper(l) iodide; 1,10-phenanthroline N-oxide; caesium carbonate In N,N-dimethyl-formamide at 120℃; Inert atmosphere To the three-necked flask, CuI (19 mg, 0.1 mmol, 10 molpercent), 1,10-phenanthroline-N-oxide (39 mg, 0.2 mmol, 20 molpercent) and Cs2CO3 (650 mg, 2.0mmol). The reaction flask was evacuated under argon. p-cyanochlorbenzene (138 mg, 1.0mmol), pyrazole (102 mg, 1.5 mmol) and DMF (2 mL) were added under an atmosphere of argon gas. The reaction was carried out at 120 °C for 72 hours until the starting reaction was complete (the reaction was complete by TLC). After completion of the reaction, a brown oil was obtained which was diluted with ethyl acetate. The inorganic salt was removed by filtration and the solvent was removed by rotary evaporation. The residue was purified by silica gel column chromatography using petroleum ether / ethyl acetate as eluant to give 1-(4-carbonitrilephenyl)pyrazole as a pale yellow oil in a yield of 51percent.
Reference: [1] Advanced Synthesis and Catalysis, 2007, vol. 349, # 17-18, p. 2673 - 2676
[2] Chemistry - A European Journal, 2014, vol. 20, # 18, p. 5231 - 5236
[3] Journal of Organic Chemistry, 2011, vol. 76, # 9, p. 3151 - 3159
[4] RSC Advances, 2016, vol. 6, # 64, p. 59550 - 59564
[5] Patent: CN104356131, 2016, B, . Location in patent: Paragraph 0316-0327
  • 4
  • [ 288-13-1 ]
  • [ 623-00-7 ]
  • [ 25699-83-6 ]
YieldReaction ConditionsOperation in experiment
98% at 90℃; for 30 h; sealed tube Following General Procedure A (90 0C, 30 hours), 1H-pyrazole (205 mg, 3.0 mmol) is coupled with 4-bromobenzonitrile (364 mg, 2.0 mmol). The crude brown oil is purified by flash chromatography on silica gel (eluent: dichloromethane / hexanes = 50/50) to provide 330 mg (98 percent isolated yield) of the desired product as a white solid. identificationMp: 89°C. <n="45"/>1H NMR (400 MHz5 CDCI3): δ 7.92-7.93 (d, 1 H1 H7), 7.75-7.78 (m, 2H, H3l5), 7.65-7.70 (m, 3H, H2,B,9), 6.46-6:47 (dd, 1H1 H8).13C NMR (100 MHz, CDCI3): δ 142.95 (C1), 142.50 (C9), 133.68 (C3,5), 126.94 (C7), 118.93 (C2,6), 118.44 (C10), 109.53 (C4), 109.15 (C8). IR (KBr) : v (cm-1) = 3153, 3136, 3066, 2226(CN), 1610, 1528, 1513, 1392, 1342, 1252, 1199, 1176, 1127, 1030, 934, 834, 813, 749, 650, 572, 545. GC/MS: rt = 18.92 min, M/Z = 169. HRMS: 170.0700 (M+H). Theoretical: 170.0718.
82% With copper(I) oxide; caesium carbonate; N-phenyl-2-pyridincarboxamide-1-oxide In acetonitrile for 20 h; Inert atmosphere; Reflux General procedure: In 50 mL round bottom flask, aryl halide (1.0 mmol), pyrazole (1.2 mmol), ligand (0.04 mmol), Cu2O (0.10 mmol), cesium carbonate (2.0 mmol), and dry solvent (20 mL) were placed under nitrogen atmosphere. The reaction mixture was heated in oil bath up to specified temperature under constant stirring for 20 h and then allowed to cool to room temperature. The reaction mixture was filtered through a plug of Celite in a fritted filter funnel and washed with ethyl acetate. If DMSO is used as solvent, it is extracted by washing the filtrate with 25 mL water for three times. The organic phase was dried over anhydrous MgSO4 and was removed under reduced pressure to provide the crude product which was purified by column chromatography on silica gel, using hexane and ethyl acetate in 3:1 ratio, respectively, as an eluent.
78% With copper(l) iodide; tetrabutylammomium bromide; N-(2-aminoethyl)-N'-{2-[(2-aminoethyl)amino]ethyl}ethane-1,2-diamine In water at 125℃; for 24 h; General procedure: Iodobenzene (1.0 mmol), imidazole (1.5 mmol), TEPA (2.0 mmol), TBAB (0.3 mmol), CuI (0.1 mmol), and 3 mL H2O were added to a 10 mL flask, which was subsequently capped with a rubber balloon. The mixture was stirred in a preheated oil bath at 125 °C for 12 h. After cooling the mixture to the room temperature, 5 mL water was added and the product was extracted by ethyl acetate (10 mL×3). The combined organic layer was washed by brine (15 mL), dried over anhydrous MgSO4, and evaporated under the reduced pressure. Further purification by silica gel column chromatography (6:1 petroleum ether/ethyl acetate) give the 1-phenyl-1H-imidazole.
Reference: [1] Angewandte Chemie - International Edition, 2007, vol. 46, # 6, p. 934 - 936
[2] Patent: WO2008/4088, 2008, A2, . Location in patent: Page/Page column 43-44
[3] Journal of Organic Chemistry, 2005, vol. 70, # 13, p. 5164 - 5173
[4] New Journal of Chemistry, 2017, vol. 41, # 8, p. 3082 - 3088
[5] European Journal of Organic Chemistry, 2004, # 4, p. 695 - 709
[6] ChemCatChem, 2014, vol. 6, # 8, p. 2373 - 2383
[7] Chemistry - A European Journal, 2014, vol. 20, # 18, p. 5231 - 5236
[8] Tetrahedron Letters, 2016, vol. 57, # 20, p. 2197 - 2200
[9] Tetrahedron, 2013, vol. 69, # 30, p. 6230 - 6233
[10] Organic and Biomolecular Chemistry, 2011, vol. 9, # 12, p. 4671 - 4684
[11] Angewandte Chemie - International Edition, 2009, vol. 48, # 2, p. 333 - 336
  • 5
  • [ 288-13-1 ]
  • [ 3058-39-7 ]
  • [ 25699-83-6 ]
Reference: [1] Chemistry - A European Journal, 2014, vol. 20, # 18, p. 5231 - 5236
[2] Catalysis Science and Technology, 2017, vol. 7, # 19, p. 4401 - 4412
  • 6
  • [ 544-92-3 ]
  • [ 151-50-8 ]
  • [ 17635-45-9 ]
  • [ 25699-83-6 ]
Reference: [1] Tetrahedron, 2001, vol. 57, # 20, p. 4397 - 4403
  • 7
  • [ 1194-02-1 ]
  • [ 25699-83-6 ]
Reference: [1] Patent: US6498172, 2002, B1,
  • 8
  • [ 109-74-0 ]
  • [ 25699-83-6 ]
Reference: [1] Angewandte Chemie - International Edition, 2017, vol. 56, # 49, p. 15693 - 15697[2] Angew. Chem., 2017, vol. 129, p. 15899 - 15903,5
  • 9
  • [ 7321-55-3 ]
  • [ 25699-83-6 ]
Reference: [1] Journal of the American Chemical Society, 2015, vol. 137, # 29, p. 9481 - 9488
  • 10
  • [ 3463-30-7 ]
  • [ 25699-83-6 ]
Reference: [1] Tetrahedron, 2001, vol. 57, # 20, p. 4397 - 4403
  • 11
  • [ 288-13-1 ]
  • [ 873-74-5 ]
  • [ 25699-83-6 ]
Reference: [1] Chemistry - A European Journal, 2014, vol. 20, # 45, p. 14619 - 14623
  • 12
  • [ 16209-02-2 ]
  • [ 25699-83-6 ]
Reference: [1] Angewandte Chemie - International Edition, 2017, vol. 56, # 49, p. 15693 - 15697[2] Angew. Chem., 2017, vol. 129, p. 15899 - 15903,5
  • 13
  • [ 25699-83-6 ]
  • [ 99662-34-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 11, p. 2955 - 2959
  • 14
  • [ 25699-83-6 ]
  • [ 368870-03-5 ]
YieldReaction ConditionsOperation in experiment
83% With borane-THF In tetrahydrofuran for 16 h; Reflux To 4-(pyrazol-1-yl)benzonitrile (see WO 2005/095343A) (1.46 g, 8.63 mmol) was added a solution of 1M borane tetrahydrofuran complex in tetrahydrofuran (93 ml, 93 mmol), followed by heating to reflux for 16 hours. After completion of the reaction, methanol (14 ml) was added to the reaction solution, followed by concentration under reduced pressure. 6N Hydrochloric acid (265 ml) was added to the residue, followed by further heating to reflux for 3 hours. After this solution was concentrated under reduced pressure, a small amount of water was added. The resulting solution was adjusted to pH 11 with a 30percent aqueous sodium hydroxide solution under ice cooling, followed by extraction with methylene chloride. The separated organic layer was dried over anhydrous sodium sulfate, and then concentrated under reduced pressure. The resulting residue was subjected to silica gel column chromatography (eluent; chloroform:methano1:28percent aqueous ammonia=90:10:1 (V/V/V)), and fractions containing the desired compound were concentrated under reduced pressure to afford the title compound (1.24 g) as a pale yellow solid. (Yield: 83percent) Mass spectrum (CI, m/z): 174 (M++1). 1H-NMR spectrum (CDCl3, ppm): 7.91 (dd, J=2.5, 0.5Hz, 1H), 7.72 (d, J=1.6Hz, 1H), 7.69-7.63 (m, 2H), 7.44-7.37 (m, 2H), 6.46 (dd, J=2.5, 1.6Hz, 1H), 3.91 (s, 2H).
83%
Stage #1: With borane-THF In tetrahydrofuran for 16 h; Reflux
Stage #2: With methanol In tetrahydrofuran
9-(a) 4-(Pyrazol-1-yl)beilzylamine To 4-(pyrazol-1-yl)benzonitrile (see WO 2005/095343A) (1.46 g, 8.63 mmol) was added a solution of 1M borage * tetrahydrofuran complex in tetrahydrofuran (93 ml, 93 mmol), followed by heating to reflux for 16 hours. After completion of the reaction, methanol (14 ml) was added to the reaction solution, followed by concentration under reduced pressure. 6N Hydrochloric acid (265 ml) was added to the residue, followed by further heating to reflux for 3 hours. After this solution was concentrated under reduced pressure, a small amount of water was added. The resulting solution was adjusted to pH 11 with a 30percent aqueous sodium hydroxide solution under ice cooling, followed by extraction with methylene chloride. The separated organic layer was dried over anhydrous sodium sulfate, and then concentrated under reduced pressure. The resulting residue was subjected to silica gel column chromatography (eluent; chloroform:methanol:28percent aqueous ammonia=90:10:1 (V/V/V)), and fractions containing the desired compound were concentrated under reduced pressure to afford the title compound (1.24 g) as a pale yellow solid. (Yield: 83percent) Mass spectrum (CI, m/z): 174 (M++1). 1H-NMR spectrum (CDCl3, δppm): 7.91 (dd, J=2.5, 0.5Hz, 1H), 7.72 (d, J=1.6Hz, 1H), 7.69-7.63 (m, 2H), 7.44-7.37 (m, 2H), 6.46 (dd, J=2.5, 1.6H, 1H), 3.91 (s, 2H).
52% With palladium 10% on activated carbon; hydrogen; lithium hydroxide In ethyl acetate at 20℃; for 16 h; Step 2. (4-(lH-Pyrazol-l-yl)phenyl)methanamine (0849) [00270] A mixture of 4-(lH-pyrazol-l-yl)benzonitrile (15 g, 88.66 mmol), Raney nickel (10 g), palladium on carbon (10 wt. percent, 1 g) and lithium hydroxide (1 g, 41.75 mmol) in EtOAc (200 mL) was evacuated and back-filled with hydrogen several times and then charged with hydrogen. The resulting mixture was stirred for 16 h at ambient temperature, then was filtered and concentrated under vacuum. The residue was purified by silica gel chromatography (eluting with a gradient of 1-10percent DCM/MeOH) resulting in 8 g (52percent) of (4-(lH-pyrazol-l- yl)phenyl)methanamine. MS (ESI) m/z 174 [M+H]+.
Reference: [1] Patent: EP2264009, 2010, A1, . Location in patent: Page/Page column 103
[2] Patent: EP2415763, 2012, A1, . Location in patent: Page/Page column 105
[3] Patent: WO2017/87837, 2017, A1, . Location in patent: Paragraph 00270
[4] Patent: US2013/123281, 2013, A1, . Location in patent: Paragraph 0127
[5] Patent: US9301951, 2016, B2, . Location in patent: Page/Page column 231
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 25699-83-6 ]

Aryls

Chemical Structure| 687635-04-7

[ 687635-04-7 ]

(3-(1H-Pyrazol-1-yl)phenyl)methanamine

Similarity: 0.85

Chemical Structure| 368870-03-5

[ 368870-03-5 ]

(4-(1H-Pyrazol-1-yl)phenyl)methanamine

Similarity: 0.85

Chemical Structure| 709-04-6

[ 709-04-6 ]

1-Phenyl-1H-pyrazole-4-carbonitrile

Similarity: 0.84

Chemical Structure| 1107632-13-2

[ 1107632-13-2 ]

(4-(1H-Pyrazol-1-yl)phenyl)methanamine hydrochloride

Similarity: 0.84

Chemical Structure| 20157-44-2

[ 20157-44-2 ]

1-(o-Tolyl)-1H-pyrazole

Similarity: 0.82

Nitriles

Chemical Structure| 709-04-6

[ 709-04-6 ]

1-Phenyl-1H-pyrazole-4-carbonitrile

Similarity: 0.84

Chemical Structure| 1101120-05-1

[ 1101120-05-1 ]

3-Formylpyrazolo[1,5-a]pyridine-5-carbonitrile

Similarity: 0.80

Chemical Structure| 74626-47-4

[ 74626-47-4 ]

1H-Indazole-5-carbonitrile

Similarity: 0.79

Chemical Structure| 103646-82-8

[ 103646-82-8 ]

5-Amino-1-(p-tolyl)-1H-pyrazole-4-carbonitrile

Similarity: 0.77

Chemical Structure| 5334-43-0

[ 5334-43-0 ]

5-Amino-1-phenyl-1H-pyrazole-4-carbonitrile

Similarity: 0.71

Related Parent Nucleus of
[ 25699-83-6 ]

Pyrazoles

Chemical Structure| 687635-04-7

[ 687635-04-7 ]

(3-(1H-Pyrazol-1-yl)phenyl)methanamine

Similarity: 0.85

Chemical Structure| 368870-03-5

[ 368870-03-5 ]

(4-(1H-Pyrazol-1-yl)phenyl)methanamine

Similarity: 0.85

Chemical Structure| 709-04-6

[ 709-04-6 ]

1-Phenyl-1H-pyrazole-4-carbonitrile

Similarity: 0.84

Chemical Structure| 1107632-13-2

[ 1107632-13-2 ]

(4-(1H-Pyrazol-1-yl)phenyl)methanamine hydrochloride

Similarity: 0.84

Chemical Structure| 20157-44-2

[ 20157-44-2 ]

1-(o-Tolyl)-1H-pyrazole

Similarity: 0.82